David Josephson MD FACS, Urology
Minimally Invasive Surgery, Surgical Oncology
Urologic Oncologist and Robotic Surgeon
Join to View Full Profile
8635 W 3rd StSte 1Los Angeles, CA 90048
Phone+1 310-854-9898
Fax+1 310-854-0627
Dr. Josephson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 2005- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1999 - 2001
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2026
American Board of Urology Urology
National Board of Physicians and Surgeons Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Indianapolis Monthly Castle Connolly, 2007, 2009-2011, 2013
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011
- Join now to see all
Clinical Trials
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsInvestigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends.James P Daniels, Devin N Patel, Gloria Cecilia Galvan, Nadine A Friedrich, Sanjay Das
Prostate Cancer and Prostatic Diseases. 2024-03-01 - 42 citationsDiagnostic Performance and Safety of Positron Emission Tomography withF-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prosta...Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, Mark A Preston, Brian T Helfand
European Urology. 2023-10-01 - 175 citationsDiagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot
Clinical Cancer Research. 2021-07-01
Professional Memberships
- Member
Other Languages
- Spanish, Farsi
External Links
- Personal websitehttp://losangelesurology.org
- Group Websitehttp://towerurology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
